Cancer biology & therapy

Cancer Biology & Therapy began in 2002 with Landes Bioscience, which Crossref still names, and has been published by Taylor & Francis from Philadelphia since 2015. Its aims and scope describe an international journal examining all aspects of the molecular basis of cancer with translational relevance to diagnosis and therapy, covering new technologies, mechanisms of action of novel agents, combination chemotherapy, pharmacogenomics and pharmacokinetics, and chemotherapeutic, biological, immunomodulatory, cell and gene therapies. It publishes original research, reviews, meeting reports, bedside-to-bench reports, letters and journal club articles under single-blind peer review, converted to full open access from volume 23 in 2022 and is now online only. Listed in DOAJ with CC BY and CC BY-NC licences and an article processing charge. Indexed in MEDLINE.